Furthermore, a multi‐stimuli activatable peptide nanodrug is designed for site‐specific delivery of different peptides, simultaneously activating the cGAS‐STING pathway and blocking PD‐1/PD‐L1 pathway, ultimately initiating robust and durable T cell anti‐tumor immunity. The gene discussed is CD274; the disease is neoplasm.